Phenomenex

Special Issues

Special Issues, Special Issues-12-01-2012, Volume 30, Issue 12

Phenomenex

Company Description

Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical, government, and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety, and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.

Chief Chromatographic Techniques Supported

  • HPLC, including HILIC, monolithic, fully porous, and coreshell technology

  • Fast LC and UHPLC

  • LC–MS

  • Preparative HPLC and process media

  • GC and GC–MS

  • Sample preparation including solid phase extraction (SPE), filtration, and vials

  • Gel permeation chromatography (GPC)

  • Gel filtration chromatography (GFC)

  • Ion exchange chromatography

  • Amino acid analysis

  • Oligonucleotide purification

  • Chiral chromatography

  • Supercritical fluid chromatography (SFC)

  • Certified reference materials

Markets Served

Phenomenex products are used worldwide in industrial, pharmaceutical, university and government research, development, quality control, and process and contract laboratories. Other markets served include clinical, chemical, biotechnology, petrochemical, food and beverage, environmental, forensic, plastics and polymers, and natural products.

Major Products/Services

Recently introduced products:

  • Kinetex® Core-shell technology UHPLC, HPLC, and PREP LC columns generate better performance than fully porous columns. The portfolio now includes 1.3 µm, 1.7 µm, 2.6 µm, and 5 µm particles for compatibility with virtually all systems and separation goals.

  • Yarra™ 3 µm size exclusion/gel filtration columns provide greater resolving power, confident recoveries, unmatched reproducibility, and are ideal for the separation of small to large proteins, biological therapeutics, and biosimilars.

  • Phree™ Phospholipid removal plates offer a fast, effective way to remove proteins and phospholipids from plasma samples without negatively affecting the recovery of target analytes.

Facility

Phenomenex is headquartered in Torrance, California, with over 100,000 square feet in facilities. The company provides direct services and support to scientists in more than 20 countries, and Phenomenex products are available worldwide through a global network of partners and distributors.

Phenomenex

411 Madrid Ave

Torrance, CA 90501

TELEPHONE

(310) 212-0555

FAX

(310) 328-7768

E-MAIL

info@phenomenex.com

WEB SITE

www.phenomenex.com

NUMBER OF EMPLOYEES

Over 700

YEAR FOUNDED

1982